A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Northwest Clinical Trials
Clinical research site in Boise, Idaho · NORTHWEST CLINICAL TRIALS, 888 N Cole Rd, Boise, ID 83704 · (208) 685-0600 · Website
4.6on Google· View on Google Maps
As of September 2026, 1 paid clinical trial is recruiting at Northwest Clinical Trials in Boise, Idaho. Active studies at this site cover conditions such as Alzheimer Disease, Dementia and Plaque, Amyloid. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Northwest Clinical Trials? We'll email you when one opens.
Recruiting clinical trials at Northwest Clinical Trials (1)
Get new-trial alerts for Northwest Clinical Trials
We'll email you whenever a new clinical trial starts recruiting at this research site in Boise, ID. Unsubscribe anytime.
More research sites in Boise
- Saint Luke's Cancer Institute - Boise (78 trials)
- Saint Alphonsus Cancer Care Center-Boise (57 trials)
- St. Luke's Boise Medical Center (6 trials)
- Treasure Valley Medical Research (6 trials)
- Saint Alphonsus Regional Medical Center (4 trials)
- ASR, LLC (4 trials)
- Boise VA Medical Center (3 trials)
- Consultants in Epilepsy & Neurology, PLLC (3 trials)
- Consultants in Epilepsy and Neurology, PLLC (3 trials)
- St. Luke's Cancer Institute: Boise (3 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.